Filing Details
- Accession Number:
- 0001415889-24-030009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-20 21:05:04
- Reporting Period:
- 2024-12-18
- Accepted Time:
- 2024-12-20 21:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646649 | Jonathan Sheena | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-18 | 338 | $165.97 | 259,434 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-18 | 1,825 | $167.25 | 257,609 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-18 | 537 | $168.15 | 257,072 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-18 | 238 | $166.18 | 47,544 | No | 4 | S | Indirect | By Caraluna 1 Trust |
| Common Stock | Disposition | 2024-12-18 | 959 | $167.18 | 46,585 | No | 4 | S | Indirect | By Caraluna 1 Trust |
| Common Stock | Disposition | 2024-12-18 | 303 | $168.04 | 46,282 | No | 4 | S | Indirect | By Caraluna 1 Trust |
| Common Stock | Disposition | 2024-12-18 | 152 | $166.01 | 47,630 | No | 4 | S | Indirect | By Caraluna 2 Trust |
| Common Srock | Disposition | 2024-12-18 | 852 | $167.07 | 46,778 | No | 4 | S | Indirect | By Caraluna 2 Trust |
| Common Stock | Disposition | 2024-12-18 | 496 | $168.02 | 46,282 | No | 4 | S | Indirect | By Caraluna 2 Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Caraluna 1 Trust |
| No | 4 | S | Indirect | By Caraluna 1 Trust |
| No | 4 | S | Indirect | By Caraluna 1 Trust |
| No | 4 | S | Indirect | By Caraluna 2 Trust |
| No | 4 | S | Indirect | By Caraluna 2 Trust |
| No | 4 | S | Indirect | By Caraluna 2 Trust |
Footnotes
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.70 to $166.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.87 to $167.82 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.8750 to $168.4350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.7000 to $166.3450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.8650 to $167.8200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.90 to $168.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.7000 to $166.1750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.8350 to $167.5900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.90 to $168.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
